(Q39263504)

10 September 2017

title

Plasma neuropeptide-Y concentrations in humans exposed to military survival training (English)

1 reference

10 September 2017

0 references

Morgan CA 3rd

1

1 reference

10 September 2017

Wang S

2

1 reference

10 September 2017

Southwick SM

3

1 reference

10 September 2017

Rasmusson A

4

1 reference

10 September 2017

Hazlett G

5

1 reference

10 September 2017

Hauger RL

6

1 reference

10 September 2017

Charney DS

7

1 reference

10 September 2017

language of work or name

English

0 references

publication date

1 May 2000

1 reference

10 September 2017

published in

Biological Psychiatry

1 reference

10 September 2017

volume

47

1 reference

10 September 2017

issue

10

1 reference

10 September 2017

page(s)

902-909

1 reference

Neuropeptide Y radio-immunoassay: characterization and application

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Measurement of dissociative states with the Clinician-Administered Dissociative States Scale (CADSS)

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Anxiolytic activity of NPY receptor agonists in the conflict test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Central and peripheral effects of repeated stress and high NaCl diet on neuropeptide Y.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Relation of leptin and neuropeptide Y in human blood and cerebrospinal fluid

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

CRF/NPY interactions: a potential role in sleep dysregulation in depression and anxiety

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Modulation of memory processing by neuropeptide Y varies with brain injection site.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Anxiolytic-like effect of neuropeptide Y (NPY), but not other peptides in an operant conflict test

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Intracerebroventricular neuropeptide Y protects against stress-induced gastric erosion in the rat

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Anxiolytic-like action of neuropeptide Y: mediation by Y1 receptors in amygdala, and dissociation from food intake effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Neuropeptide Y: an overview of central distribution, functional aspects, and possible involvement in neuropsychiatric illnesses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Interaction between neuropeptide Y and noradrenaline on central catecholamine neurons.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Expression of catecholamine-synthesizing enzymes, peptidylglycine alpha-amidating monooxygenase, and neuropeptide Y mRNA in the rat adrenal medulla after acute systemic nicotine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Neuropeptide Y is released together with noradrenaline from the human heart during exercise and hypoxia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Altered cerebrospinal fluid neuropeptide Y and peptide YY immunoreactivity in anorexia and bulimia nervosa.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Relation between plasma and cerebrospinal fluid levels of 3-methoxy-4-hydroxyphenylglycol

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Co-release of neuropeptide Y and catecholamines during physical exercise in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Increases in plasma neuropeptide Y concentrations during sympathetic activation in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Dissociation of adrenal androgen and cortisol levels in acute stress.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Plasma neuropeptide Y-like immunoreactivity and catecholamines during various degrees of sympathetic activation in man

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Plasma neuropeptide Y (NPY) increases in humans in response to the alpha 2 antagonist yohimbine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Low baseline and yohimbine-stimulated plasma neuropeptide Y (NPY) levels in combat-related PTSD

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Neuropeptide Y injected in the paraventricular hypothalamus: a powerful stimulant of feeding behavior

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Localization of neuropeptide Y binding sites in the zona glomerulosa of the bovine adrenal gland.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Neuropeptide Y-related peptides and their receptors--are the receptors potential therapeutic drug targets?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Modulation of anxiety and neuropeptide Y-Y1 receptors by antisense oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Reduced neuropeptide Y concentrations in suicide brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Neuropeptide Y and peptide YY as possible cerebrospinal fluid markers for major depression and schizophrenia, respectively

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

Mitogenic effect of neuropeptide Y in rat vascular smooth muscle cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2899%2900239-5

10.1016/S0006-3223(99)00239-5

7 January 2021

Identifiers

DOI

1 reference

10 September 2017

1 reference